Canada: Summary Judgment Motion In S. 8 Case Dismissed (Intellectual Property Weekly Abstracts - Week Of March 13, 2017)

PATENT DECISIONS

Summary Judgment Motion in S. 8 Case Dismissed

Apotex Inc. v Abbott Laboratories, Limited, 2017 ONSC 1348
Drug: lansoprazole

In this case, Abbott and Takeda brought a summary judgment motion as against Apotex, to dismiss the s. 8 proceeding in its entirety. As a preliminary matter, the Court held that the issues raised in the Applicant's factum were not enumerated in their Notice of Motion. The motion was restricted to the elements in the questions as originally posed: "(i) that Apotex' submission did not comply with the FDA or FDA Regulations when it was filed, and it was not compliant as of April 2007; and (ii) in the absence of the NOC Regulations, the FDA and FDA Regulations did not permit an Apo-lansoprazole NOC to be issued in April 2007. Therefore, no NOC could or would have issued to Apotex at that time in the absence of the NOC Regulations." (para 48)

The Court enumerated the law that applied to summary judgment motions in Ontario. It then considered the evidence. In this case, Apotex had received a Patent Hold letter. It then received correspondence revoking that letter and indicating that Apotex' Apo-lansoprazole product was no longer considered approvable. Additional bioequivalence studies, using different diet conditions, were needed. When those were submitted, bioequivalence was not demonstrated. The matter was referred to the Scientific Committee on Bioavailability and Bioequivalence, which recommended against approval. Health Canada issued a NON-W. Apotex used Health Canada's Reconsideration Process, which resulted in a finding that Apo-lansoprazole was cleared for sale. After the expert panel's recommendations, Health Canada spent another month reviewing the product and recommending descriptive changes to the usage circular and descriptions of the product. An NOC was then issued. The Court emphasized that this was the exact same product that had received the original Patent Hold letter.

The evidence before the Court was that an NOC would have issued at the first Patent Hold letter, but for the NOC Regulations. Furthermore, Health Canada's subsequent actions in relation to the request for further studies, would not have resulted in the revocation of that NOC. The Court made a finding that the issuance of the Patent Hold letter "definitively establishes that a NOC for the generic product not only could have, but would have been issued on April 17 or 18, 2007" but for the litigation under the NOC Regulations. The Court also stated that it was not persuaded that Apo-lansoprazole was not legally approvable as of that time. The Court held that the Applicant's position on the summary judgment motion was without factual or legal foundation or merit.

The Court also considered the Applicants' arguments that the FCA's decision in Apotex v. Canada (Health), 2012 FCA 322 [Omeprazole FCA] should apply in this situation. However, the Court distinguished the statements by the FCA as arising in a different contextual circumstance. The question of whether a generic is entitled to s. 8 damages is entirely separate from whether the Minister's decisions arising out of the drug approvals process may be challenged. A patentee does not have standing to impugn decisions made under the FDA Regulations. The Court further distinguished Omeprazole FCA on its facts.

Thus, the Court dismissed the motion for summary judgment. The Court further held that its findings were applicable on the merits. The Court held that the facts of the case plainly establish that Apotex has a s. 8 claim, and the question is about quantum. In addition, the Court held that due to its findings with respect to Omeprazole FCA, the Applicants will not be permitted to revisit avenues relating to the conduct of Health Canada. The Court appointed himself trial judge and narrowed the questions for trial.

COPYRIGHT DECISIONS

Go Cyber Shopping ordered to stop its activities and pay a $12.7 Million award for selling game copiers and mod chips for Nintendo game systems

Nintendo of America Inc. v. King, 2017 FC 246

Nintendo has been awarded an injunction, $11,760,000 in statutory damages and $1,000,000 in punitive damages for the trafficking of infringing devices that were alleged to allow the use of pirated games in Nintendo DS, 3DS and Wii video game consoles. These devices included mod chips and game copiers designed for use with downloaded ROMs.

The following was ordered against the Respondent Go Cyber Shopping (2005) Ltd. The individual respondent had reached a settlement agreement on all issues, including liability and quantum of damages, before the end of the hearing.

The Court found copyright in the Header Data for each of the three game systems, as well as the video games themselves. The Defendant was said to provide the directions on how to copy or download the Header Data if it was not already provided with the device. This was found to be either primary or secondary infringement of the copyright held by Nintendo.

The Court considered what is meant by the definition of a Technological Protection Measure in the Copyright Act, and held that access control TPMs do not need to employ any barrier to copying in order to be effective. Therefore, the physical configuration of Nintendo's game cartridges, including the shape of the card and the arrangement of the electrical pins, was held to be a TPM. The boot up security checks, encryption/scrambling, format and Wii Copy Protection Codes were also held to be TPMs.

The Court disregarded arguments seeking to narrow the meaning of "circumvent" when applied to TPMs, and held that the game copiers circumvent the physical configuration TPM. The game copiers were also found to circumvent the boot up security check TPM and the encryption/scrambling TPM. The Wii TPM was found to be circumvented by the use of mod chips.

The Respondent raised a "homebrew" affirmative defence, arguing for the interoperability of computer programs and the potential availability of homebrew software. The Court held that the primary purpose of the Respondent's devices is to play pirated copies of Nintendo games, and that the Respondent did not meet its burden of establishing the exemption.

The Court awarded the maximum of $20,000 in statutory damages per work, which was found to be 585 Nintendo games and the three header data works. In doing so, the Court noted that actual infringement of copyright is not necessary for an award of statutory damages for TPM circumvention. It was also held that the damages would not be assessed per TPM circumvented, but rather per work infringed.

Punitive damages were also awarded, to reflect the objectives of retribution, deterrence, and denunciation. The Court held that the Respondent knowingly and deliberately sold circumvention devices, promoted such activities to its customers, had done so for years and operated under a misleading unregistered business name. The evidence also suggested plans to expand to Nintendo's next generation of game consoles.

Damages of $52,527.07 for breach of copyright where licence conditional on payment of fees did not pass to respondent through foreclosure proceedings

Ankenman Associates Architects Inc. v. 0981478 B.C. Ltd., 2017 BCSC 333

In this petition, the Supreme Court of British Columbia found the corporate respondent liable for damages for breach of copyright based on the unauthorized use of architectural plans and drawings in respect of an apartment development.

The petitioner, a small architectural firm, had originally prepared the plans for Murray's Walk Development Ltd ("MWDL"), a developer who later went bankrupt and failed to pay all of the petitioner's fees. MWDL's property, including the lands and the plans for the project, was sold to the corporate respondent, a second developer, in the course of foreclosure proceedings.

There was no dispute as to the ownership of copyright in the plans. Rather, at issue was whether the corporate respondent had acquired MWDL's right to use the plans by virtue of having purchased all of MWDL's property in the foreclosure proceedings.

The Court concluded that the consent given to MWDL for the use of the drawings was conditional on payment of the petitioner's fees in full. The licence ended when payment was not provided. The Court found that the terminated licence was not capable of being transferred to the respondents, who as a result used the drawings without consent. The Court noted that even if the licence did transfer to the respondents, the petitioner revoked its consent or alternatively, the licence was conditional on payment in full which was never provided. In either case, the respondents would have used the drawings without consent.

The Court disagreed with the respondents claim that the petitioner was estopped, by issue estoppel or cause of action estoppel, from seeking the relief sought in this petition because it was a respondent to the foreclosure proceedings but decided not to object to the relief sought at that time. The Court found that the issue raised in these proceedings was not addressed in the foreclosure proceedings.

The Court noted that there was no clearly established practice on how to assess damages in this context. The Court awarded in the amount the corporate respondent would have been required to pay the petitioner in order for individual respondent to provide services based on the drawings. The Court concluded that damages should not be awarded against the individual respondent, finding that he was in a difficult position and appears to have acted in good faith.

TRADEMARKS DECISIONS

Court pierces corporate veil where Third Party used for the improper purpose of thwarting Default Judgment

Asics Corporation v. 9153-2267 Québec Inc., 2017 FC 257

The Court dismissed the corporate Third Party's motion opposing the execution of a Writ of Seizure and Sale and seeking various other types of relief. The Plaintiff opposed the motion on the basis that the Third Party is being used by Joseph Nassar and Jean-Pierre Nassar (the "Two Individuals") for the improper purpose of thwarting a Default Judgment issued against the Defendant, after it was found to have infringed the Plaintiff's rights in certain trademarks.

The Writ was executed at two locations formerly used by the Defendant to sell its products, and now used by the Third Party to sell similar products. The Third Party sought to nullify and set aside the seizure, on the basis that it legitimately owns the goods that were seized and it is not a party named in the Writ. The Third Party submitted that the onus was upon the Plaintiff to meet the strict test for lifting the corporate veil, to permit the Plaintiff to execute the Default Judgment against the seized goods and the Third Party.

The Plaintiff submitted that the Third Party is under the complete control of the two Individuals, and was incorporated for the sole purpose of evading the Default Judgment, and therefore, the Third Party's corporate veil should be pierced. The Court agreed and concluded that the Plaintiff had met the strict test for lifting the corporate veil to permit the Plaintiff to execute the Default Judgment against the Third Party. The Court found that the evidence established on a balance of probabilities that the Third Party is the "alter ego of its principals, Joseph Nassar and Jean-Pierre Nassar". The evidence also established, inter alia, that the business was transferred from the Defendant to the Third Party for the dishonest and improper purpose of evading the Default Judgment, and potentially other judgments, issued against the Defendant by this Court.

Damages in the amount of $8,500 for passing off as a Dairy Queen franchise for a period of less than one month

Dairy Queen Canada, Inc. v. M.Y. Sundae Inc., 2017 BCSC 358

In this summary trial, the Court dealt with various issues relating to the termination of a Dairy Queen franchise agreement, including the Plaintiff's claim for damages based on the tort of passing off.

The Defendants had purchased the restaurant conducting business in the name of the DQ Grill & Chill and had agreed to be bound by the terms and conditions of the franchise agreement with Dairy Queen Canada, Inc., the Plaintiff. Ultimately, the working relationship between the Plaintiff and the Defendants broke down. In August 2013, the parties executed a Mutual Cancellation and Release. The Release suspended termination of the franchise agreement until February 1, 2014, allowing, inter alia , the Defendants an opportunity to sell their business and recoup their investment. In January 2014, the Defendants were advised that they were not operating in accordance with the terms of the Cancellation and Release and were told that the Plaintiff was "accelerating" the Agreement's termination date to January 8, 2014, in accordance with its terms. The Defendants conceded that they continued to operate the DQ Grill & Chill until April 8, 2014; that they sold products representative of a Dairy Queen franchise while doing so; and, that the premises were identified as a Dairy Queen.

On the issue of passing off, t he Defendants acknowledged that the Plaintiff had established the first element of the tort of passing off, namely, the existence of "goodwill". The Court was also satisfied that the second and third elements of the tort had been made out.

On the second element, the evidence established that the Defendants presented themselves as a Dairy Queen franchise between January 8, 2014, when the Plaintiff terminated the Agreement, and April 8, 2014, when the Dairy Queen signage was removed from the premises.

On the third element of the tort, namely damages, the Court accepted that the Defendants' conduct interfered with the Plaintiff's goodwill and drew an inference of damages as a result. However, the Court determined that the period for assessing damages for passing off was shorter than that which was held out by the Plaintiff. Based on the evidence, the Court found that the Plaintiff represented to the Defendants that the last possible date for the DQ Grill & Chill to close and "de-identify" as a Dairy Queen franchise was March 10, and not January 8, 2014. The Court awarded damages in the amount of $8,500 for passing off in these circumstances, which represented approximately one third of the amount sought by the Plaintiff based on a reduced time frame.

INDUSTRY UPDATES

Health Canada has released a Guidance Document — Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.